| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Methylprednisolone sodium succinate 40mg powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| céfuroxime 250 mg, fiole de poudre pour solution injectable (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| ceftriaxone 2 g, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| ceftriaxone 250 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Vecuronium bromide 4mg powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| idarubicin hydrochloride 5mg powder for injection solution vial (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Plicamycin 2.5 g powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| ceftriaxone 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Aldesleukin 18megaunits powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Methylprednisolone sodium succinate 2g powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Anidulafungin 100mg powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Human immunoglobulin g 2.5g powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Decitabine 50 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Spectinomycin 2g powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Romiplostim 500 microgram powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| poudre de 500 mg d'immunoglobuline contre le virus varicella-zoster pour solution injectable en flacon (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| idarubicin hydrochloride 10mg powder for injection solution vial (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Human immunoglobulin g 5g powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| C1 esterase inhibitor 500 units powder for injection solution 8mL vial |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Bacitracin 50,000units powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Rubella immunoglobulin 25,000iu powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Agalsidase beta 35 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Follitropin alfa 150u powder for injection solution ampule (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely somatrem 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely recombinant human antithrombin III 1750 international unit/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Somatrem 10 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Thiothixene hydrochloride 5mg powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Streptozocin 1 g powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Siltuximab 100 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Siltuximab 400 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely dalbavancin (as dalbavancin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Tedizolid phosphate 200 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Belinostat 500 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Porfimer sodium 15 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Hydralazine hydrochloride 20mg injection powder vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| chlorhydrate de diacétylmorphine 10 mg, pour injection (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| chlorhydrate de diacétylmorphine 30 mg, pour injection (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| chlorhydrate de diacétylmorphine 100 mg, pour injection (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| chlorhydrate de diacétylmorphine 500 mg, pour injection |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| complexe hémagglutinine-toxine botulique de type A 500 unités, pour injection (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| pénicilline G 1 200 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| pénicilline g 600 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| amoxicilline 250 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| amoxicilline 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| amoxicilline 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| céfotaxime 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| céfotaxime 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| céfoxitine 2 g, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| ceftazidime 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| ceftazidime 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| ceftazidime 2 g, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| céfradine 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| céfradine 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| colistiméthate sodique 500 000 unités, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| colistiméthate sodique 1 000 000 unités, pour injection (poudre pour reconstitution) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropine (efficacité biologique relative) 36 UI (12 mg), cartouche de poudre pour solution injectable (médicament clinique) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ifosfamide 1 g powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ifosfamide 2 g powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Treosulfan 1 g powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Doxorubicin hydrochloride 10 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Epirubicin hydrochloride 10 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Epirubicin hydrochloride 20 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely epirubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Mitomycin 20 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| etoposide 100mg injection (pdr for recon) (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely vindesine sulfate 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely indometacin (as indometacin sodium trihydrate) 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Dantrolene sodium 20 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Dolasetron mesilate 20 mg powder for solution for injection ampoule |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely hemin 313 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely sargramostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Canakinumab 150mg powder for injection solution (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Temsirolimus 25mg/mL powder for conventional release solution for injection vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Somatropin(rbe) 12 mg powder for solution for injection cartridge |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Epoetin beta 10,000iu powder for conventional release solution for injection cartridge |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Factor VIII 500iu/von Willebrand factor 1100iu powder for conventional release solution for injection vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Somatropin(rmc) 3.33 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely acetazolamide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Thymosin alpha 1 1.6mg powder for conventional release solution for injection vial |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Epoetin beta 100,000iu powder for conventional release solution for injection vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely somatropin(rmc) 1.33 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely albiglutide 30 milligram/1 pen powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Treosulfan 5 g powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Epoetin beta 20,000iu powder for conventional release solution for injection cartridge (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely peginterferon alfa-2b 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely ixabepilone 45 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely teicoplanin 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Albiglutide 50 mg powder for solution for injection pen |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Disodium pamidronate 30 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
FHIR